Reta-Solution

Reta-Solution 10 mg research-grade lyophilized peptide powder supplied in a sterile glass vial. Reta-Solution is the research formulation of retatrutide (LY3437943), an investigational multi-receptor peptide agonist targeting GIP, GLP-1, and glucagon receptors. It is utilized exclusively in experimental models focused on obesity, glycemic regulation, and metabolic signaling pathways.

For diluting lyophilized peptide powders, use a sterile, suitable solvent such as bacteriostatic water (BAC), which helps maintain stability and reduce contamination risk. For convenient dosing and safe handling,
see Bacteriostatic water – 10 ml.

Research Overview

Reta-Solution represents a next-generation multi-agonist platform engaging GIP, GLP-1, and glucagon receptors simultaneously. It is employed in controlled laboratory environments to investigate coordinated regulation of body weight, glucose homeostasis, and systemic energy balance. No therapeutic or clinical claims are implied.

Primary Research Areas

• Triple receptor agonism: Mechanistic evaluation of combined GIP/GLP-1/glucagon signaling, receptor bias, and downstream metabolic pathways.
• Obesity & body-weight models: Preclinical studies assessing adiposity, food intake, and energy expenditure under multi-agonist stimulation.
• Glycemic & metabolic regulation: Experimental analysis of glucose tolerance, insulin response, hepatic glucose flux, and systemic metabolic control.